Ovarian cancer begins in the ovaries but is typically undetected until it is found in the pelvis and abdomen, making it difficult to treat and commonly fatal. There are three types of ovarian cancer that differentiate depending on location of where it began: cancer than begins in the cells on the outside of the ovaries, cancer that begins in the egg-producing cells, and cancer that begins in the hormone-producing cells. Risk factors for ovarian cancer include inherited gene mutations, a family history of ovarian cancer, increasing age, and never being pregnant. Treatments for ovarian cancer most frequently include surgery and chemotherapy. Stage II ovarian cancer occurs when cancer is present in both ovaries and has spread to other organs and tissues within the pelvis, yet not to the lymph nodes, distant sites or organs, or the lining of the abdomen. Stage II can be divided into three subgroups. Stage IIA occurs when the cancer is located in the uterus and/or fallopian tubes. Stage IIB is characterized by cancer in pelvic organs (bladder, rectum). Stage IIC is when cancer has spread to pelvic organs (like in IIA and IIB) and cancer cells were found when the fluid from the washings from the abdomen were examined.
Stage Ii Ovarian Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Ii Ovarian Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 147 products for the study of Stage Ii Ovarian Cancer that can be applied to Chromatin Immunoprecipitation, Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.